Article

Merced Sun-Star on 2016-10-26 16:36

EpiPen competitor will re-launch after being pulled off market in 2015

Drugmaker Kaleo will resume sales of its product Auvi-Q, which was recalled over potential malfunctions that could give patients the wrong dose.

Related news

EpiPen competitor will re-launch after being pulled off market Chicago Tribune
Richmond , France
U.S. approves first generic competitor to EpiPen pressherald.com
MFDA approves new generic competitor to EpiPen masslive.com
U.S. approves new generic competitor to EpiPen staradvertiser.com
Texas , Hendersonville
LEpipen competitor to launch in February lowellsun.com
Kaléo’s EpiPen competitor to launch in February reviewjournal.com
Washington , Capitol Hill
MYou still can’t buy this EpiPen competitor, eight months later marketwatch.com
Arizona
Upcoming competitor to Mylan’s EpiPen has equally sleazy pricing rep Ars Technica
Iowa
MKaleo Inc. says its competitor to Mylan's EpiPen will be available for $360 starting Feb. 14 marketwatch.com
Mylan sees lower EpiPen volumes ahead of generic launch bizjournals.com
Japan’s potential SpaceX competitor achieves mixed results in first launch TechCrunch
Earth , Hokkaido Prefecture , Japan
MGeneric EpiPen may not launch in time for allergic kids going back to school marketwatch.com
Mylan Will Launch First Generic EpiPen At Half The Price After Outcry Over Price Hike huffingtonpost.com
Germany
Farage: EU 'Terrified' of UK Being Competitor on Doorstep breitbart.com
Ireland , Europe , France , United Kingdom , Brussels
CVS cuts cost for generic EpiPen competitor WCPO
Texas , Hendersonville
CVS slashes cost for generic EpiPen competitor whnt.com
US approves new generic competitor to EpiPen neworleanscitybusiness.com